Methotrexate from Japan
Methotrexate is a folic acid antagonist containing pteridine heterocyclic rings, used as an antineoplastic and immunosuppressant drug. Classified under HTS 2934.99.4700 as a pharmaceutical drug with 'other heterocyclic compounds' structure. Its complex ring system with multiple nitrogens defines its Chapter 29 placement.
Duty Rate — Japan → United States
3.7%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Submit FDA IND/NDA documentation for API import; maintain GMP-certified supply chain; beware reclassification risk if purity <99% suggesting intermediate status